Jaguar Health: Joshua Mailman reports 9.99% stake
The reported ownership is divided between sole and shared voting and dispositive authority.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Jaguar Health, Inc. (JAGX) common stock is the subject of Amendment No. 1 to Schedule 13G, in which Joshua Mailman reports beneficial ownership of 189,617 shares, or 9.99% of the class. He reports sole voting and dispositive power over 186,205 shares and shared voting and dispositive power over 3,412 shares.
Key Figures
Key Terms
beneficially owned regulatory
Sole power to vote or to direct the vote regulatory
Sole power to dispose or to direct the disposition regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.